Publications database

Displaying 1251 - 1260 of 1406

Drugnet Europe 36

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

DRID protocol draft

This is a draft version of the protocol for the drug-related infectious diseases epidemiological indicator, one of five key indicators used by the EMCDDA to monitor the drug situation in Europe.

Prosecution of drug users in Europe — varying pathways to similar objectives

Researching and analysing the responses of the criminal-justice systems to drug offenders throughout Europe is one of the EMCDDA’s priorities. This study is the result of a decision taken by the EMCDDA’s...

Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs

Since the mid-1990s, GHB – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Some EU countries have reported worries over GHB’s surreptitious...

Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs

Since the mid-1990s, ketamine – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Concern over ketamine centres on its unpredictability in producing...

Measuring prevalence and incidence of drug use

Reducing the prevalence of drug use through prevention is a key feature of many policies at local, national and international levels. The first target of the European Union drugs strategy (2000–04) is...

Medicinal cannabis and derivatives — a legal analysis of the options, their limitations, and current practice in the EU

This report has been produced by the EMCDDA as a practical development of its legal database on drugs. Medicinal cannabis is one of the topics in the field of drugs that produces...

General report of activities 2001

The General report of activities is an annual publication providing a detailed progress report of the EMCDDA's activities over a 12-month period. Published every spring, it catalogues the Centre's achievements in each...

National prevalence estimates of problem drug use in the European Union, 1995-2000

Prevalence of problem drug use (PDU) is one of five key indicators used by the EMCDDA to provide more comparable, scientifically based estimates of the prevalence of more severe patterns of drug...

Drug users and the law in the EU

Drug laws in the European Union (EU) seek continuously to strike a balance between punishment and treatment. The three United Nations (UN) conventions on drugs, limit drug use exclusively to medical or...